Insider Transactions in Q1 2021 at Tabula Rasa Health Care, Inc. (TRHC)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 11
2021
|
Calvin H Knowlton CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
8,000
-0.22%
|
$336,000
$42.77 P/Share
|
Mar 11
2021
|
Orsula V Knowlton CO-PRESIDENT |
SELL
Open market or private sale
|
Direct |
8,000
-0.22%
|
$336,000
$42.77 P/Share
|
Mar 11
2021
|
Andrea Carolan Speers Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,218
-9.18%
|
$273,592
$44.14 P/Share
|
Mar 11
2021
|
Andrea Carolan Speers Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,612
+28.22%
|
$1,170,928
$44.14 P/Share
|
Mar 01
2021
|
Samira Beckwith |
BUY
Exercise of conversion of derivative security
|
Direct |
2,577
+17.81%
|
$2,577
$1.32 P/Share
|
Mar 01
2021
|
Michael J. Purcell |
BUY
Grant, award, or other acquisition
|
Direct |
481
+3.16%
|
-
|
Mar 01
2021
|
Gordon Tunstall |
BUY
Grant, award, or other acquisition
|
Direct |
635
+4.52%
|
-
|
Feb 17
2021
|
Orsula V Knowlton CO-PRESIDENT |
SELL
Open market or private sale
|
Indirect |
24,000
-0.92%
|
$1,152,000
$48.79 P/Share
|
Feb 17
2021
|
Calvin H Knowlton CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
24,000
-0.92%
|
$1,152,000
$48.79 P/Share
|
Feb 10
2021
|
Gordon Tunstall |
SELL
Open market or private sale
|
Direct |
1,000
-7.25%
|
$57,000
$57.0 P/Share
|
Feb 10
2021
|
Gordon Tunstall |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+6.76%
|
$1,000
$1.56 P/Share
|
Feb 09
2021
|
Orsula V Knowlton CO-PRESIDENT |
SELL
Open market or private sale
|
Direct |
2,903
-0.39%
|
$153,859
$53.26 P/Share
|
Feb 08
2021
|
Orsula V Knowlton CO-PRESIDENT |
SELL
Open market or private sale
|
Direct |
5,097
-0.14%
|
$280,335
$55.03 P/Share
|
Feb 08
2021
|
Calvin H Knowlton CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
8,000
-0.18%
|
$432,000
$54.74 P/Share
|
Jan 29
2021
|
Calvin H Knowlton CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Indirect |
46,875
+5.96%
|
-
|
Jan 29
2021
|
Calvin H Knowlton CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+7.88%
|
-
|
Jan 29
2021
|
Orsula V Knowlton CO-PRESIDENT |
BUY
Grant, award, or other acquisition
|
Indirect |
75,000
+7.92%
|
-
|
Jan 29
2021
|
Orsula V Knowlton CO-PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
46,875
+5.92%
|
-
|
Jan 29
2021
|
Andrea Carolan Speers Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,075
+25.51%
|
-
|
Jan 29
2021
|
Brian W Adams CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
28,125
+36.35%
|
-
|
Jan 29
2021
|
Michael Greenhalgh CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
28,125
+14.28%
|
-
|
Jan 27
2021
|
Brian W Adams CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
12,000
-5.38%
|
$720,000
$60.0 P/Share
|
Jan 27
2021
|
Brian W Adams CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+5.1%
|
$36,000
$3.11 P/Share
|
Jan 27
2021
|
Michael Greenhalgh CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
16,000
-10.21%
|
$960,000
$60.0 P/Share
|
Jan 27
2021
|
Michael Greenhalgh CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+9.27%
|
$48,000
$3.11 P/Share
|
Jan 21
2021
|
Michael Greenhalgh CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-2.09%
|
$156,000
$52.2 P/Share
|
Jan 21
2021
|
Michael Greenhalgh CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+2.05%
|
$9,000
$3.11 P/Share
|
Jan 19
2021
|
Calvin H Knowlton CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
8,000
-0.57%
|
$416,000
$52.44 P/Share
|
Jan 19
2021
|
Orsula V Knowlton CO-PRESIDENT |
SELL
Open market or private sale
|
Direct |
8,000
-0.57%
|
$416,000
$52.44 P/Share
|
Jan 13
2021
|
Gordon Tunstall |
SELL
Open market or private sale
|
Direct |
1,000
-7.25%
|
$50,000
$50.0 P/Share
|
Jan 13
2021
|
Gordon Tunstall |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+6.76%
|
$1,000
$1.56 P/Share
|
Jan 12
2021
|
Andrea Carolan Speers Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
905
-3.24%
|
$41,630
$46.35 P/Share
|
Jan 12
2021
|
Michael Greenhalgh CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
966
-0.68%
|
$44,436
$46.35 P/Share
|
Jan 12
2021
|
Brian W Adams CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,809
-0.85%
|
$83,214
$46.35 P/Share
|
Jan 04
2021
|
Brian W Adams CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
6,160
-1.42%
|
$252,560
$41.76 P/Share
|
Jan 04
2021
|
Michael Greenhalgh CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,568
-0.89%
|
$105,288
$41.76 P/Share
|
Jan 04
2021
|
Andrea Carolan Speers Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,301
-5.59%
|
$217,341
$41.83 P/Share
|